SpectraCure AB (publ) (STO:SPEC)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1596
+0.0050 (3.23%)
Aug 8, 2025, 10:51 AM CET
3.23%
Market Cap15.02M
Revenue (ttm)n/a
Net Income (ttm)-23.33M
Shares Out97.13M
EPS (ttm)-0.24
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume513,687
Average Volume2,723,632
Open0.1570
Previous Close0.1546
Day's Range0.1552 - 0.1598
52-Week Range0.1500 - 5.1100
Beta0.36
RSI33.23
Earnings DateAug 15, 2025

About SpectraCure AB

SpectraCure AB (publ) engages in the development of cancer treatment system. It develops Q-PRO, a laser device; and IDOSE software with interstitial photodynamic therapy system for the treatment of prostate cancer. The company was incorporated in 2003 and is based in Lund, Sweden. [Read more]

Sector Healthcare
Founded 2003
Employees 16
Stock Exchange Nasdaq Stockholm
Ticker Symbol SPEC
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.